Absci Corporation Stock News

VANCOUVER, Wash., Jan. 05, 2022 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeuti

VANCOUVER, Washington, Dec. 30, 2021 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the thera

VANCOUVER, Washington, Dec. 30, 2021 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therape

VANCOUVER, Wash., Dec. 29, 2021 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeuti

Absci Corp (NASDAQ:ABSI) fell 6.8% on Thursday . The company traded as low as $9.49 and last traded at $9.49. 4,001 shares changed hands during mid-day trading, a decline of 99% from the average session volume of 279,165 shares. The stock had previously closed at $10.18. A number of brokerages have weighed in on ABSI. []

Shares of Absci Corp (NASDAQ:ABSI) gapped up prior to trading on Tuesday . The stock had previously closed at $10.24, but opened at $10.98. Absci shares last traded at $11.13, with a volume of 20 shares changing hands. A number of analysts recently weighed in on the stock. Cowen started coverage on shares of Absci []

Vitality Biopharma (OTCMKTS:VBIO) and Absci (NASDAQ:ABSI) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, analyst recommendations, valuation, profitability, institutional ownership, risk and earnings. Insider & Institutional Ownership 0.3% of Vitality Biopharma shares are held by institutional investors. Comparatively, 27.3% []

Inhibitor Therapeutics (OTCMKTS:INTI) and Absci (NASDAQ:ABSI) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, dividends, institutional ownership, risk, profitability and valuation. Profitability This table compares Inhibitor Therapeutics and Abscis net margins, return on equity and return on []

Absci Corp (NASDAQ:ABSI)s stock price hit a new 52-week low on Monday . The company traded as low as $9.40 and last traded at $9.51, with a volume of 837 shares. The stock had previously closed at $10.56. A number of brokerages recently weighed in on ABSI. UBS Group began coverage on shares of Absci []

AIkido Pharma (NASDAQ:AIKI) and Absci (NASDAQ:ABSI) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, earnings, analyst recommendations, institutional ownership, profitability, valuation and dividends. Analyst Ratings This is a summary of current ratings and target prices for AIkido Pharma and []

Absci (NASDAQ:ABSI) and Anavex Life Sciences (NASDAQ:AVXL) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, earnings, institutional ownership, analyst recommendations, profitability, dividends and risk. Analyst Ratings This is a summary of current recommendations and price targets for Absci and []

iSpecimen (NASDAQ:ISPC) and Absci (NASDAQ:ABSI) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, profitability, valuation, risk and earnings. Valuation and Earnings This table compares iSpecimen and Abscis gross revenue, earnings per share (EPS) and valuation. []

Absci (NASDAQ:ABSI) and AIkido Pharma (NASDAQ:AIKI) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, analyst recommendations, risk, profitability, institutional ownership, valuation and earnings. Valuation & Earnings This table compares Absci and AIkido Pharmas top-line revenue, earnings per share (EPS) []

Charles River Laboratories International (NYSE:CRL) and Absci (NASDAQ:ABSI) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, valuation, risk, analyst recommendations, earnings, dividends and profitability. Profitability This table compares Charles River Laboratories International and Abscis net margins, return on equity []

Luna Innovations (NASDAQ:LUNA) and Absci (NASDAQ:ABSI) are both small-cap business services companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, profitability, valuation, risk and earnings. Profitability This table compares Luna Innovations and Abscis net margins, return on equity and return []